These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2559 related articles for article (PubMed ID: 28057034)
41. Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma. Cacicedo J; Fernandez I; Del Hoyo O; Navarro A; Gomez-Iturriaga A; Pijoan JI; Martinez-Indart L; Escudero J; Gomez-Suarez J; de Zarate RO; Perez JF; Bilbao P; Rades D Clin Transl Oncol; 2017 Nov; 19(11):1337-1349. PubMed ID: 28540535 [TBL] [Abstract][Full Text] [Related]
42. Outcomes of Elderly Patients Who Receive Combined Modality Therapy for Locally Advanced Non-Small-Cell Lung Cancer. Zaki M; Dominello M; Dyson G; Gadgeel S; Wozniak A; Miller S; Paximadis P Clin Lung Cancer; 2017 Jan; 18(1):e21-e26. PubMed ID: 27567356 [TBL] [Abstract][Full Text] [Related]
43. FDG and FMISO PET-guided dose escalation with intensity-modulated radiotherapy in lung cancer. Thureau S; Dubray B; Modzelewski R; Bohn P; Hapdey S; Vincent S; Anger E; Gensanne D; Pirault N; Pierrick G; Vera P Radiat Oncol; 2018 Oct; 13(1):208. PubMed ID: 30352608 [TBL] [Abstract][Full Text] [Related]
44. [Prognostic value of (18)F-fluorodeoxyglucose uptake in patients with non-small cell lung cancer treated by concurrent chemoradiotherapy]. Zhang HQ; Yu JM; Meng X; Yue JB; Feng R; Ma L Zhonghua Zhong Liu Za Zhi; 2010 Aug; 32(8):603-6. PubMed ID: 21122413 [TBL] [Abstract][Full Text] [Related]
45. Prognostic values of mid-radiotherapy Kim N; Cho H; Yun M; Park KR; Lee CG Radiat Oncol; 2019 Feb; 14(1):27. PubMed ID: 30717809 [TBL] [Abstract][Full Text] [Related]
46. Watch the weathercock: changes in re-staging 18F-FDG PET/CT scan predict the probability of relapse in locally advanced non-small cell lung cancer. Marquez-Medina D; Martin-Marco A; Popat S Clin Transl Oncol; 2016 Feb; 18(2):228-32. PubMed ID: 26203801 [TBL] [Abstract][Full Text] [Related]
47. Efficacy of 18F-fluorodeoxyglucose positron emission tomography/computed tomography as a predictor of response in locally advanced non-small-cell carcinoma of the lung. Roy S; Pathy S; Kumar R; Mohanti BK; Raina V; Jaiswal A; Taywade S; Garg K; Thulkar S; Mohan A; Mathur S; Behera D Nucl Med Commun; 2016 Feb; 37(2):129-38. PubMed ID: 26544097 [TBL] [Abstract][Full Text] [Related]
48. A SUV Ye L; Xu F; Shi S; Zeng Z; Jin X; Huang Y; Lu C; Gu J; Ge D; He J Clin Transl Oncol; 2018 Aug; 20(8):1026-1034. PubMed ID: 29327241 [TBL] [Abstract][Full Text] [Related]
49. Prognostic value of volumetric metabolic parameter changes determined by during and after radiotherapy-based Chen HHW; Su WC; Guo HR; Lee BF; Chiu NT Kaohsiung J Med Sci; 2019 Mar; 35(3):151-159. PubMed ID: 30887722 [TBL] [Abstract][Full Text] [Related]
50. Utility of (18)F-FDG PET/CT in patients with advanced squamous cell carcinoma of the uterine cervix receiving concurrent chemoradiotherapy: a parallel study of a prospective randomized trial. Liu FY; Lai CH; Yang LY; Wang CC; Lin G; Chang CJ; Chang WY; Huang SH; Huang YE; Peng NJ; Hong JH; Chao A; Chou HH; Chang YC; Yen TC Eur J Nucl Med Mol Imaging; 2016 Sep; 43(10):1812-23. PubMed ID: 27160224 [TBL] [Abstract][Full Text] [Related]
51. FDG PET/CT texture analysis for predicting the outcome of lung cancer treated by stereotactic body radiation therapy. Lovinfosse P; Janvary ZL; Coucke P; Jodogne S; Bernard C; Hatt M; Visvikis D; Jansen N; Duysinx B; Hustinx R Eur J Nucl Med Mol Imaging; 2016 Jul; 43(8):1453-60. PubMed ID: 26830299 [TBL] [Abstract][Full Text] [Related]
52. Volume-based parameters of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography improve outcome prediction in early-stage non-small cell lung cancer after surgical resection. Hyun SH; Choi JY; Kim K; Kim J; Shim YM; Um SW; Kim H; Lee KH; Kim BT Ann Surg; 2013 Feb; 257(2):364-70. PubMed ID: 22968069 [TBL] [Abstract][Full Text] [Related]
53. Long term follow-up of neoadjuvant chemotherapy for non-small cell lung cancer (NSCLC) investigating early positron emission tomography (PET) scan as a predictor of outcome. Romine PE; Martins RG; Eaton KD; Wood DE; Behnia F; Goulart BHL; Mulligan MS; Wallace SG; Kell E; Bauman JE; Patel SA; Vesselle HJ BMC Cancer; 2019 Jan; 19(1):70. PubMed ID: 30642285 [TBL] [Abstract][Full Text] [Related]
54. Usefulness of interim FDG-PET after induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck receiving sequential induction chemotherapy followed by concurrent chemoradiotherapy. Yoon DH; Cho Y; Kim SY; Nam SY; Choi SH; Roh JL; Lee SW; Song SY; Lee JH; Kim JS; Cho KJ; Kim SB Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):118-25. PubMed ID: 20675065 [TBL] [Abstract][Full Text] [Related]
56. FDG PET/CT for assessing the resectability of NSCLC patients with N2 disease after neoadjuvant therapy. Kremer R; Peysakhovich Y; Dan LF; Guralnik L; Kagna O; Nir RR; Bar-Shalom R Ann Nucl Med; 2016 Feb; 30(2):114-21. PubMed ID: 26613715 [TBL] [Abstract][Full Text] [Related]
57. Texture analysis of Nakajo M; Jinguji M; Nakabeppu Y; Nakajo M; Higashi R; Fukukura Y; Sasaki K; Uchikado Y; Natsugoe S; Yoshiura T Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):206-214. PubMed ID: 27613542 [TBL] [Abstract][Full Text] [Related]
58. Value of metabolic tumor volume on repeated 18F-FDG PET/CT for early prediction of survival in locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy. Huang W; Fan M; Liu B; Fu Z; Zhou T; Zhang Z; Gong H; Li B J Nucl Med; 2014 Oct; 55(10):1584-90. PubMed ID: 25214640 [TBL] [Abstract][Full Text] [Related]
59. Introducing FDG PET/CT-guided chemoradiotherapy for stage III NSCLC in low- and middle-income countries: preliminary results from the IAEA PERTAIN trial. Konert T; Vogel WV; Paez D; Polo A; Fidarova E; Carvalho H; Duarte PS; Zuliani AC; Santos AO; Altuhhova D; Karusoo L; Kapoor R; Sood A; Khader J; Al-Ibraheem A; Numair Y; Abubaker S; Soydal C; Kütük T; Le TA; Canh NX; Bieu BQ; Ha LN; Belderbos JSA; MacManus MP; Thorwarth D; Hanna GG Eur J Nucl Med Mol Imaging; 2019 Oct; 46(11):2235-2243. PubMed ID: 31367906 [TBL] [Abstract][Full Text] [Related]
60. Stereotactic Ablative Radiation Therapy for Lung Oligometastases: Predictive Parameters of Early Response by Mazzola R; Fiorentino A; Di Paola G; Giaj Levra N; Ricchetti F; Fersino S; Tebano U; Pasetto S; Ruggieri R; Salgarello M; Alongi F J Thorac Oncol; 2017 Mar; 12(3):547-555. PubMed ID: 28126325 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]